Sunshine Biopharma (Sunshine Biopharma) Accounts Payable : $3.62 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma Accounts Payable?

Sunshine Biopharma's Accounts Payable for the quarter that ended in Mar. 2024 was $3.62 Mil.

Sunshine Biopharma's quarterly Accounts Payable increased from Sep. 2023 ($2.22 Mil) to Dec. 2023 ($2.59 Mil) and increased from Dec. 2023 ($2.59 Mil) to Mar. 2024 ($3.62 Mil).

Sunshine Biopharma's annual Accounts Payable increased from Dec. 2021 ($0.04 Mil) to Dec. 2022 ($2.80 Mil) but then declined from Dec. 2022 ($2.80 Mil) to Dec. 2023 ($2.59 Mil).

Sunshine Biopharma Accounts Payable Historical Data

The historical data trend for Sunshine Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma Accounts Payable Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.10

0.06

0.04

2.80

2.59

Sunshine Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															2.74	1.76	2.22	2.59	3.62

Sunshine Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Sunshine Biopharma Accounts Payable Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma (Sunshine Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).